Immix Biopharma Inc (IMMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 29,956 | 22,675 | 16,141 | 8,219 | 1,352 |
| Operating Income | -29,956 | -22,675 | -16,141 | -8,219 | -1,352 |
| Interest Expense | 0 | 0 | 0 | 1 | 180 |
| Other Income | 556 | 1,017 | 572 | 0 | -22,846 |
| Pre-tax Income | -29,401 | -21,657 | -15,569 | -8,219 | -24,378 |
| Income Tax | 38 | 41 | 26 | 10 | 6 |
| Net Income Continuous | -29,439 | -21,698 | -15,596 | -8,230 | -24,384 |
| Minority Interests | N/A | -85 | -170 | N/A | N/A |
| Net Income | $-29,439 | $-21,613 | $-15,426 | $-8,230 | $-24,384 |
| EPS Basic Total Ops | -0.89 | -0.76 | -0.89 | -0.59 | -6.64 |
| EPS Basic Continuous Ops | -0.89 | -0.77 | -0.90 | -0.59 | -6.64 |
| EPS Diluted Total Ops | -0.89 | -0.76 | -0.89 | -0.59 | -6.64 |
| EPS Diluted Continuous Ops | -0.89 | -0.77 | -0.90 | -0.59 | -6.64 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.76 | -0.89 | -0.59 | N/A |
| EBITDA(a) | $-29,592 | $-22,559 | $-16,136 | $-8,217 | $-1,291 |